WClasses

PHARM 155 - Introduction to Drug Information Fundamentals

This course provides students with basic skills in retrieving and assessing drug information and medical literature. The foundation acquired in this course will be used throughout the Integrated Patient Focused Care series in critically appraising literature to support an evidence-based patient care model.

Prerequisites

Pharmacy students only

Corequisites

None

Antirequisites

None

Offerings

Spring 2026 [1265]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 00142780 / 124

Spring 2025 [1255]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014395133 / 14013:30 - 15:20 Th

Spring 2024 [1245]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014445124 / 12513:00 - 14:50 W

Spring 2023 [1235]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014564119 / 12313:00 - 14:50 W

Spring 2022 [1225]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014301119 / 12009:00 - 10:50 WPHR 1004Sherilyn Houle

Spring 2021 [1215]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0413897120 / 12214:30 - 16:20 F Sherilyn Houle

Spring 2020 [1205]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014315122 / 123 Khrystine Waked

Spring 2019 [1195]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014339121 / 12116:00 - 17:50 WPHR 1004Sherilyn Houle

Spring 2018 [1185]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014232119 / 12011:00 - 12:50 MPHR 1004Sherilyn Houle

Spring 2017 [1175]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014226117 / 12011:00 - 12:50 MPHR 1004Sherilyn Houle

Spring 2016 [1165]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014237122 / 12016:30 - 18:20 TIHB 2018David Edwards

Spring 2015 [1155]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014309119 / 12013:00 - 14:50 TPHR 1004Sherilyn Houle

Spring 2014 [1145]

SectionClassEnrolledTimeDaysLocationInstructor
LEC 0014634119 / 12013:00 - 14:50 WPHR 1004

UW Flow Ratings

Liked: 50.00%

50.00%

Easy: 100.00%

100.00%

Useful: 100.00 %

100.00%

PHARM 155 leads to

PHARM 380 - Landmark Clinical Trials